Effective antiprotease-antibiotic treatment of experimental anthrax
<p>Abstract</p> <p>Background</p> <p>Inhalation anthrax is characterized by a systemic spread of the challenge agent, <it>Bacillus anthracis</it>. It causes severe damage, including multiple hemorrhagic lesions, to host tissues and organs. It is widely belie...
Main Authors: | MacAfee Rebecca, Weinstein Raymond S, Hopkins Svetlana, Popova Taissia G, Popov Serguei G, Fryxell Karl J, Chandhoke Vikas, Bailey Charles, Alibek Ken |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2005-04-01
|
Series: | BMC Infectious Diseases |
Online Access: | http://www.biomedcentral.com/1471-2334/5/25 |
Similar Items
-
Acceleration of epithelial cell syndecan-1 shedding by anthrax hemolytic virulence factors
by: Chandhoke Vikas, et al.
Published: (2006-02-01) -
Whole proteome analysis of mouse lymph nodes in cutaneous anthrax.
by: Taissia G Popova, et al.
Published: (2014-01-01) -
Chemokine-Releasing Microparticles Improve Bacterial Clearance and Survival of Anthrax Spore-Challenged Mice.
by: Taissia G Popova, et al.
Published: (2016-01-01) -
Immune-modulating Activity of Hydrogel Microparticles Contributes to the Host Defense in a Murine Model of Cutaneous Anthrax
by: Allison L. Teunis, et al.
Published: (2017-08-01) -
Protease–Antiprotease Imbalance in Bronchiectasis
by: Martina Oriano, et al.
Published: (2021-06-01)